Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapy

OBJECTIVE: Data on the clinical activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer (NSCLC) and uncommon EGFR mutations remain insufficient. This study aimed to investigate the effect of first-line EGFR-TKIs or platinum-ba...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chin J Cancer Res
Hlavní autoři: Shi, Jinpeng, Yang, Hui, Jiang, Tao, Li, Xuefei, Zhao, Chao, Zhang, Limin, Zhao, Sha, Liu, Xiaozhen, Jia, Yijun, Wang, Yan, Xi, Lei, Zhang, Shijia, Su, Chunxia, Ren, Shengxiang, Zhou, Caicun
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5775013/
https://ncbi.nlm.nih.gov/pubmed/29353977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21147/j.issn.1000-9604.2017.06.09
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky